oxazolidin-2-one has been researched along with Moraxella Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, WJ; Courtney, M; Ford, CW; Friis, JM; Gadwood, RC; Gordeev, MF; Hackbarth, CJ; Lam, S; Lopez, S; Morin, SE; Mortell, KH; Palandra, J; Patel, DV; Raju, B; Schaadt, RD; Singh, U; Trias, J; Wu, C; Yuan, Z; Zhou, J; Zurenko, GE | 1 |
Amarnath, PV; Chakrabarti, R; Iqbal, J; Kumar, MS; Kumar, NS; Mallik, A; Rajagopalan, R; Sarnaik, H; Sreenivas, K; Takhi, M; Trehan, S | 1 |
2 other study(ies) available for oxazolidin-2-one and Moraxella Infections
Article | Year |
---|---|
New antibacterial tetrahydro-4(2H)-thiopyran and thiomorpholine S-oxide and S,S-dioxide phenyloxazolidinones.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Combinatorial Chemistry Techniques; Haemophilus Infections; Haemophilus influenzae; Lipid Metabolism; Male; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Morpholines; Oxazolidinones; Oxides; Oxygen Compounds; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2003 |
In vitro and in vivo antibacterial evaluation of DRF 8417, a new oxazolidinone.
Topics: Animals; Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamases; Disease Models, Animal; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Mice; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Oxazolidinones; Specific Pathogen-Free Organisms; Treatment Outcome | 2007 |